Cited by 3,481Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Open access

Gibb, W R, Lees, A J·1988·Journal of Neurology, Neurosurgery & Psychiatry

DOI 10.1136/jnnp.51.6.745PMC PMC1033142

Open this paper in CoChat — free account Open PDF

Abstract

The Lewy body is a distinctive neuronal inclusion that is always found in the substantia nigra and other specific brain regions in Parkinson's disease. It is mainly composed of structurally altered neurofilament, and occurs wherever there is excessive loss of neurons. It occurs in some elderly individuals and rarely in other degenerative diseases of the central nervous system. In 273 brains of patients dying from disorders other than Parkinson's disease, the age-specific prevalence of Lewy bodies increased from 3.8% to 12.8% between the sixth and ninth decades. Associated pathological findings suggest that these cases of incidental Lewy body disease are presymptomatic cases of Parkinson's disease, and confirm the importance of age (time) in the evolution of the disease. In view of the common and widespread occurrence of this disorder we propose that endogenous mechanisms operating in early life may be more important than environmental agents in the pathogenesis of Lewy bodies and Parkinson's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/jnnp.51.6.745

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. A., & SEITELBERGER, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,650
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 535
AETIOLOGY OF PARKINSON'S DISEASE
Calne, D., & Langston, J. W. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90802-4 · Cited by 469
Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?
Kosaka, K., Yoshimura, M., Ikeda, K., & Budka, H. (1984) · PubMed · Cited by 401
Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
Forno, L. S., Langston, J. W., DeLanney, L. E., Irwin, I., & Ricaurte, G. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200403 · Cited by 351
Parkinson's disease in 65 pairs of twins and in a set of quadruplets
Ward, C. D., Duvoisin, R. C., Ince, S. E., Nutt, J., Eldridge, R., & Calne, D. B. (1983) · Neurology · doi:10.1212/wnl.33.7.815 · Cited by 347
PHASE AND ELECTRON MICROSCOPIC OBSERVATIONS OF LEWY BODIES AND MELANIN GRANULES IN THE SUBSTANTIA NIGRA AND LOCUS CAERULEUS IN PARKINSONʼS DISEASE
Duffy, P. E., & Tennyson, V. M. (1965) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196507000-00003 · Cited by 345
THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE
Gibb, W. R. G., & Lees, A. J. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01147.x · Cited by 325
Self-citation
Esophageal Lewy bodies associated with ganglion cell loss in achalasia
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90079-9 · Cited by 305
Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · PubMed · Cited by 295

Show all 39 references

Research works printed but not linked: 7

Gibb WRG. The Lewy body and Parkinson's disease. In: Clifford Rose F, ed. Parkinson's Disease: Clinical and Experimental Advances. London: John Libbey and Co, 1987:3-11.
Oppenheimer D. Neuropathology of progressive autonomic failure. In: Bannister R, ed. Autonomic failure. Oxford University Press, London, 1983:267-83.
Sigwald J, Lapresle J, Raverdy P, Recondo NJ. Atrophie cerebelleuse familiale avec association de lesions nigeriennes et spinales. Presse Med 1964;72:557-62.
Vogt C, Vogt 0. Erkrankungen der GroBhirnrinde im Lichte der Topistik, Pathoklise und Pathoarchitektonik. J Psychol Neurol 1922;28:1-171.
Hamada S, Ishii T. The Lewy body in the brain of the aged. Adv Neurol Sci 1963;7:184-6.
Hirai S. Ageing of the substantia nigra. Adv Neurol Sci 1968;12:845-9.
Hassler R. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938;48:387-476.

Sorted by citations

Items 401–500 of 1,022

Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model
Kingsbury, A. E., Bandopadhyay, R., Silveira‐Moriyama, L., Ayling, H., Kallis, C., Sterlacci, W., Maeir, H., Poewe, W. H., & Lees, A. J. (2010) · Movement Disorders · doi:10.1002/mds.23305 · Cited by 152
Self-citation
Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG
Zhu, K., van Hilten, J. J., & Marinus, J. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.06.006 · Cited by 147
Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia
Ohlin, K. E., Francardo, V., Lindgren, H. S., Sillivan, S. E., O’Sullivan, S. S., Luksik, A. S., Vassoler, F. M., Lees, A. J., Konradi, C. L., & Cenci, M. A. (2011) · Brain · doi:10.1093/brain/awr165 · Cited by 140
Self-citation
MR Imaging of the Substantia Nigra at 7 T Enables Diagnosis of Parkinson Disease
Cosottini, M., Frosini, D., Pesaresi, I., Costagli, M., Biagi, L., Ceravolo, R., Bonuccelli, U., & Tosetti, M. (2014) · Radiology · doi:10.1148/radiol.14131448 · Cited by 141
Early diagnosis of Parkinson's disease
Becker, G., Müller, A., Braune, S., Büttner, T., Benecke, R., Greulich, W., Klein, W., Mark, G., Rieke, J., & Thümler, R. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1309-9 · Cited by 146
Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology
Asahina, M., Vichayanrat, E., Low, D. A., Iodice, V., & Mathias, C. J. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303135 · Cited by 139
Tremor stability index: a new tool for differential diagnosis in tremor syndromes
di Biase, L., Brittain, J.-S., Shah, S. A., Pedrosa, D. J., Cagnan, H., Mathy, A., Chen, C. C., Martín-Rodríguez, J. F., Mir, P., Timmerman, L., et al. (2017) · Brain · doi:10.1093/brain/awx104 · Cited by 140
The Gut and Parkinson's Disease—A Bidirectional Pathway
Santos, S. F., de Oliveira, H. L., Yamada, E. S., Neves, B. C., & Pereira, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00574 · Cited by 148
Square wave jerks in parkinsonian syndromes.
Rascol, O., Sabatini, U., Simonetta‐Moreau, M., Montastruc, J., Rascol, A., & Clanet, M. (1991) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.7.599 · Cited by 140
Parkinson's disease: piecing together a genetic jigsaw
Dekker, M. C. J. (2003) · Brain · doi:10.1093/brain/awg172 · Cited by 140
Role of parkin mutations in 111 community‐based patients with early‐onset parkinsonism
Kann, M., Jacobs, H., Mohrmann, K., Schumacher, K., Hedrich, K., Garrels, J., Wiegers, K., SCHWINGER, E., Pramstaller, P. P., Breakefield, X. O., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10179 · Cited by 140
Nighttime sleep problems and daytime sleepiness in Parkinson's disease
Verbaan, D., van Rooden, S. M., Jeukens‐Visser, M., Marinus, J., & van Hilten, J. J. (2007) · Movement Disorders · doi:10.1002/mds.21727 · Cited by 139
Morphological differences in Parkinson’s disease with and without rest tremor
Benninger, D. H., Thees, S., Kollias, S., Bassetti, C. L., & Waldvogel, D. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0092-2 · Cited by 144
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease
Rizzo, G., Martinelli, P., Manners, D. N., Scaglione, C. L. M., Tonon, C., Cortelli, P., Malucelli, E., Capellari, S., Testa, C. M., Parchi, P., et al. (2008) · Brain · doi:10.1093/brain/awn195 · Cited by 139
Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease
Bolitho, S. J., Naismith, S. L., Rajaratnam, S. M. W., Grunstein, R. R., Hodges, J. R., Terpening, Z., Rogers, N., & Lewis, S. J. G. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2013.10.016 · Cited by 139
Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics
Pan, Y., & Nicolazzo, J. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.009 · Cited by 131
Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson’s Disease
Vivacqua, G., Latorre, A., Suppa, A., Nardi, M., Pietracupa, S., Mancinelli, R., Fabbrini, G., Colosimo, C., Gaudio, E., & Berardelli, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151156 · Cited by 137
Olfactory function distinguishes vascular parkinsonism from Parkinson's disease
Katzenschlager, R. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.035287 · Cited by 137
Increased Iron in the Substantia Nigra Compacta of the MPTP‐Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental Microanalysis
Temlett, J. A., Landsberg, J. P., Watt, F., & Orime, G. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010134.x · Cited by 137
Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease
Cerasa, A., Hagberg, G. E., Peppe, A., Bianciardi, M., Gioia, M. C., da Costa, A. L. C., Castriota-Scanderbeg, A., Caltagirone, C., & Sabatini, U. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.09.014 · Cited by 136
How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology
Borghammer, P. (2017) · Movement Disorders · doi:10.1002/mds.27138 · Cited by 143
What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia
Minett, T., Thomas, A. J., Wilkinson, L., Daniel, S., Sanders, J., Richardson, J. L., Littlewood, E., Myint, P., Newby, J., & McKeith, I. G. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.995 · Cited by 136
Regional brain volumes distinguish PSP, MSA‐P, and PD: MRI‐based clinico‐radiological correlations
Paviour, D. C., Price, S. L., Jahanshahi, M., Lees, A. J., & Fox, N. C. (2006) · Movement Disorders · doi:10.1002/mds.20877 · Cited by 136
Self-citation
A controlled, longitudinal study of dementia in Parkinson's disease.
Biggins, C. A., Boyd, J. L., Harrop, F. M., Madeley, P., Mindham, R. H. S., Randall, J. I., & SPOKES, E. G. S. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.7.566 · Cited by 135
Drug‐induced parkinsonism: a review
Montastruc, J., Llau, M. E., Rascol, O., & Sénard, J. (1994) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1994.tb00808.x · Cited by 135
Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16‐year outcome evaluation of the Denbighshire cohort
Hobson, P., & Meara, J. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4261 · Cited by 138
Multiple Modes of Impulsivity in Parkinson's Disease
Nombela, C., Rittman, T., Robbins, T. W., & Rowe, J. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085747 · Cited by 142
Dopaminergic Function and Dopamine Transporter Binding Assessed With Positron Emission Tomography in Parkinson Disease
Ribeiro, M. J., Vidailhet, M., Loc’h, C., Dupel, C. P., Nguyen, J. P., Ponchant, M., Dollé, F., Peschanski, M., Hantraye, P., Césaro, P., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.4.580 · Cited by 134
Effects of a NR2B selective NMDA glutamate antagonist, CP‐101,606, on dyskinesia and parkinsonism
Nutt, J. G., Gunzler, S. A., Kirchhoff, T., Hogarth, P., Weaver, J. L., Krams, M., Jamerson, B., Menniti, F. S., & Landen, J. W. (2008) · Movement Disorders · doi:10.1002/mds.22169 · Cited by 133
Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms
Mu, J., Chaudhuri, К. R., Bielza, C., de Pedro-Cuesta, J., Larrañaga, P., & Martínez‐Martín, P. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00301 · Cited by 140
A Study of Emotional Processing in Parkinson's Disease
Benke, T., Bösch, S., & Andree, B. (1998) · Brain and Cognition · doi:10.1006/brcg.1998.1013 · Cited by 131
Transdermal nicotine in PD
Vieregge, A., Sieberer, M. G., Jacobs, H., Hagenah, J., & Vieregge, P. (2001) · Neurology · doi:10.1212/wnl.57.6.1032 · Cited by 131
Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia
Mollenhauer, B., Trenkwalder, C., von Ahsen, N., Bibl, M., Steinacker, P., Brechlin, P., Schindehütte, J., Poser, S., Wiltfang, J., & Otto, M. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000094871 · Cited by 132
The rotenone model of Parkinson's disease
Perier, C., Bové, J., Vila, M., & Przedborski, S. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00144-9 · Cited by 131
MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy‐parkinsonism, and Parkinson's disease
Longoni, G., Agosta, F., Kostić, V., Stojković, T., Pagani, E., Stošić-Opinćal, T., & Filippi, M. (2010) · Movement Disorders · doi:10.1002/mds.23293 · Cited by 129
Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort
Fereshtehnejad, S., Montplaisir, J. Y., Pelletier, A., Gagnon, J., Berg, D., & Postuma, R. B. (2017) · Movement Disorders · doi:10.1002/mds.26989 · Cited by 131
Targeting urate to reduce oxidative stress in Parkinson disease
Crotty, G. F., Ascherio, A., & Schwarzschild, M. A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.017 · Cited by 134
Evolution of the response to levodopa during the first 4 years of therapy
Nutt, J. G., Carter, J. H., Lea, E. S., & Sexton, G. J. (2002) · Annals of Neurology · doi:10.1002/ana.10189 · Cited by 130
Assessing whole brain perfusion changes in patients with REM sleep behavior disorder
Mazza, S., Soucy, J., Gravel, P., Michaud, M., Postuma, R. B., Massicotte-Marquez, J., Décary, A., & Montplaisir, J. Y. (2006) · Neurology · doi:10.1212/01.wnl.0000242879.39415.49 · Cited by 131
Utility of susceptibility-weighted MRI in differentiating Parkinson’s disease and atypical parkinsonism
Gupta, D. K., Saini, J. S., Kesavadas, C., Sarma, P. S., & Kishore, A. (2010) · Neuroradiology · doi:10.1007/s00234-010-0677-6 · Cited by 130
Significance of123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: It can be a specific marker for Lewy body disease
Taki, J., Yoshita, M., Yamada, M., & Tonami, N. (2004) · Annals of Nuclear Medicine · doi:10.1007/bf02984560 · Cited by 130
Overexpression of human α-synuclein causes dopamine neuron death in primary human mesencephalic culture
Zhou, W., Schaack, J. B., Zawada, W. M., & Freed, C. R. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03292-9 · Cited by 129
Defining at‐risk populations for Parkinson's disease: Lessons from ongoing studies
Berg, D., MAREK, K. L., Ross, G. W., & Poewe, W. H. (2012) · Movement Disorders · doi:10.1002/mds.24985 · Cited by 128
Neuromelanin Magnetic Resonance Imaging in Parkinson's Disease and Multiple System Atrophy
Matsuura, K., Maeda, M., Yata, K., Ichiba, Y., Yamaguchi, T., Kanamaru, K., & Tomimoto, H. (2013) · European Neurology · doi:10.1159/000350291 · Cited by 128
Reduced striatal tyrosine hydroxylase in incidental Lewy body disease
Beach, T. G., Adler, C. H., Sue, L. I., Peirce, J. B., Bachalakuri, J., Dalsing-Hernandez, J. E., Lue, L. F., Caviness, J. N., Connor, D. J., Sabbagh, M. N., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0313-7 · Cited by 128
Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson’s disease from multiple system atrophy
Zange, L., Noack, C., Hahn, K., Stenzel, W., & Lipp, A. (2015) · Brain · doi:10.1093/brain/awv138 · Cited by 130
Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study
Wakisaka, Y., Furuta, A., Tanizaki, Y., Kiyohara, Y., Iida, M., & Iwaki, T. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0750-x · Cited by 129
A comparative study of odor identification and odor discrimination deficits in Parkinson's disease
Boesveldt, S., Verbaan, D., Knol, D., Visser, M., van Rooden, S. V., van Hilten, J. V., & Berendse, H. (2008) · Movement Disorders · doi:10.1002/mds.22155 · Cited by 138
Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study
Ponsen, M. M., Stoffers, D., Twisk, J. W. R., Wolters, E. C., & Berendse, H. W. (2009) · Movement Disorders · doi:10.1002/mds.22534 · Cited by 127
α-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals
Klos, K. J., Ahlskog, J. E., Josephs, K. A., Apaydın, H., Parisi, J. E., Boeve, B. F., DeLucia, M. W., & Dickson, D. W. (2006) · Neurology · doi:10.1212/01.wnl.0000204179.88955.fa · Cited by 127
Treatment of dystonic clenched fist with botulinum toxin
Cordivari, C., Misra, V. P., Catania, S., & Lees, A. J. (2001) · Movement Disorders · doi:10.1002/mds.1186 · Cited by 127
Self-citation
Feeling of presence in Parkinson's disease
Fénelon, G., Soulas, T., de Langavant, L. C., Trinkler, I., & Bachoud‐Lévi, A. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.234799 · Cited by 126
Postural instability and gait are associated with severity and prognosis of Parkinson disease
van der Heeden, J. F., Marinus, J., Martínez‐Martín, P., Rodríguez‐Blázquez, C., Geraedts, V. J., & van Hilten, J. J. (2016) · Neurology · doi:10.1212/wnl.0000000000002768 · Cited by 126
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Koeglsperger, T., Rumpf, S.-L., Schließer, P., Struebing, F. L., Brendel, M., Levin, J., Trenkwalder, C., Höglinger, G. U., & Herms, J. W. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00622-7 · Cited by 145
Redox Reactions of the α-Synuclein−Cu2+ Complex and Their Effects on Neuronal Cell Viability
Wang, C., Liu, L., Zhang, L., Peng, Y., & Zhou, F. (2010) · Biochemistry · doi:10.1021/bi1010909 · Cited by 126
Abnormal functional connectivity of the amygdala is associated with depression in Parkinson's disease
Hu, X., Song, X., Yuan, Y., Erfeng, L., Liu, J., Liu, W., & Liu, Y. (2014) · Movement Disorders · doi:10.1002/mds.26087 · Cited by 126
Future thinking in Parkinson's disease: An executive function?
Vito, S. D., Gamboz, N., Brandimonte, M. A., Barone, P., Amboni, M., & Sala, S. D. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2012.03.001 · Cited by 125
Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson's and related diseases
Ohmichi, T., Mitsuhashi, M., Tatebe, H., Kasai, T., El‐Agnaf, O. M. A., & Tokuda, T. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.11.021 · Cited by 129
Predictors of health-related quality of life in Parkinson's disease
Kuhlman, G. D., Flanigan, J. L., Sperling, S. A., & Barrett, M. J. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.05.009 · Cited by 125
Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment
Mattila, P. M., Röyttä, M., Lönnberg, P., Marjamäki, P., Helenius, H. Y. M., & Rinne, J. O. (2001) · Acta Neuropathologica · doi:10.1007/s004010100372 · Cited by 125
Tau gene and Parkinson's disease: a case-control study and meta-analysis
Healy, D. G. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.026203 · Cited by 125
Dopaminergic function in familial Parkinson's disease: A clinical and 18F‐dopa positron emission tomography study
Piccini, P. P., Morrish, P., Turjanski, N., Sawle, G. V., Burn, D. J., Weeks, R. A., Mark, M. H., Maraganore, D. M., Lees, A. J., & Brooks, D. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410213 · Cited by 125
Self-citation
Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging
Wu, P., Wang, J., Peng, S., Ma, Y., Zhang, H., Guan, Y., & Zuo, C. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.02.013 · Cited by 124
Early Life Stress, Depression And Parkinson’s Disease: A New Approach
Dallé, E., & Mabandla, M. V. (2018) · Molecular Brain · doi:10.1186/s13041-018-0356-9 · Cited by 131
Parkinsonian Syndromes
Williams, D. R., & Litvan, I. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000436152.24038.e0 · Cited by 132
Supplement 4: Canadian Guidelines on Parkinson's Disease
Grimes, D., Gordon, J., Snelgrove, B., Lim-Carter, I., Fon, E. A., Martin, W. R. W., Wieler, M., Suchowersky, O., Rajput, A. H., Lafontaine, A. L., et al. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710001516x · Cited by 124
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7)
Hering, R., Strauss, K. M., Tao, X., Bauer, A., Woitalla, D., Mietz, E.-M., Petrovic, S., Bauer, P., Schaible, W., Müller, T. H., et al. (2004) · Human Mutation · doi:10.1002/humu.20089 · Cited by 123
Extrapyramidal Signs in Patients With Probable Alzheimer Disease
López, O. L., Wisnieski, S. R., Becker, J. T., Boiler, F., & DeKosky, S. T. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550200033007 · Cited by 124
Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease
Boddy, F., Rowan, E. N., Lett, D. J., O'Brien, J. T., McKeith, I. G., & Burn, D. J. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1709 · Cited by 124
Genomewide association study for onset age in Parkinson disease
Latourelle, J. C., Pankratz, N., Dumitriu, A., Wilk, J. B., Goldwurm, S., Pezzoli, G., Mariani, C. B., DeStefano, A. L., Halter, C. A., Gusella, J. F., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-98 · Cited by 123
Integrated molecular landscape of Parkinson’s disease
Klemann, C. J. H. M., Martens, G. J. M., Sharma, M., Martens, M. B., Ole Isacson, A., Gasser, T., Visser, J. E., & Poelmans, G. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0015-3 · Cited by 129
Regional differences in the severity of Lewy body pathology across the olfactory cortex
Silveira‐Moriyama, L., Holton, J. L., Kingsbury, A. E., Ayling, H., Petrie, A., Sterlacci, W., Poewe, W. H., Maier, H., Lees, A. J., & Révész, T. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.006 · Cited by 123
Self-citation
Neuropsychologic assessment of patients for movement disorder surgery
Saint‐Cyr, J. A., & Tr�panier, L. L. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5 · Cited by 92
Hearing impairment in Parkinson's disease: Expanding the nonmotor phenotype
Vitale, C., Marcelli, V., Allocca, R., Santangelo, G., Riccardi, P., Erro, R., Amboni, M., Pellecchia, M. T., Cozzolino, A., Longo, K., et al. (2012) · Movement Disorders · doi:10.1002/mds.25149 · Cited by 121
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait
Tessitore, A., Amboni, M., Cirillo, G., Corbo, D., Picillo, M., Russo, A., Vitale, C., Santangelo, G., Erro, R., Cirillo, M., et al. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3066 · Cited by 129
Deep brain stimulation and cognitive functions in Parkinson's disease: A three‐year controlled study
Zangaglia, R., Pacchetti, C., Pasotti, C., Mancini, F., Servello, D., Sinforiani, E., Cristina, S., Sassi, M., & Nappi, G. (2009) · Movement Disorders · doi:10.1002/mds.22603 · Cited by 121
Lack of LTP-like plasticity in primary motor cortex in Parkinson's disease
Suppa, A., Marsili, L., Belvisi, D., Conte, A., Iezzi, E., Modugno, N., Fabbrini, G., & Berardelli, A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.11.020 · Cited by 125
Gait analysis in patients with Parkinson's disease and motor fluctuations: Influence of levodopa and comparison with other measures of motor function
O’Sullivan, J. D., Said, C. M., Dillon, L., Hoffman, M., & Hughes, A. J. (1998) · Movement Disorders · doi:10.1002/mds.870130607 · Cited by 121
Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy
Wang, Y., Hancock, A. M., Bradner, J. M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D. R., Jankovic, J. J., Zabetian, C. P., Kim, H. M., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.006 · Cited by 121
LRRK2 G2019S in Families with Parkinson Disease Who Originated from Europe and the Middle East: Evidence of Two Distinct Founding Events Beginning Two Millennia Ago
Zabetian, C. P., Hutter, C. M., Yearout, D., Lopez, A. N., Factor, S. A., Griffith, A., Leis, B. C., Bird, T. D., Nutt, J. G., Higgins, D. S., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/508025 · Cited by 121
Increase of Preproenkephalin mRNA Levels in the Putamen of Parkinson Disease Patients with Levodopa-Induced Dyskinesias
Calon, F., Birdi, S., Rajput, A. H., Hornykiewicz, O., Bédard, P. J., & Paolo, T. D. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.2.186 · Cited by 121
Planning ability in Parkinson's disease is influenced by the COMT val 158 met polymorphism
Foltynie, T., Goldberg, T. E., Lewis, S. J. G., Blackwell, A. D., Kolachana, B. S., Weinberger, D. R., Robbins, T. W., & Barker, R. A. (2004) · Movement Disorders · doi:10.1002/mds.20118 · Cited by 122
Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)
Monastero, R., Cicero, C. E., Baschi, R., Davì, M., Luca, A., Restivo, V., Zangara, C., Fierro, B., Zappia, M., & Nicoletti, A. S. Q. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8800-4 · Cited by 122
Increased Visual Dependence in Parkinson's Disease
Azulay, J., Mesure, S., Amblard, B., & Pouget, J. (2002) · Perceptual and Motor Skills · doi:10.2466/pms.2002.95.3f.1106 · Cited by 120
Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease
Khan, N. L., Katzenschlager, R., Watt, H., Bhatia, K. P., Wood, N. W., Quinn, N. P., & Lees, A. J. (2004) · Neurology · doi:10.1212/01.wnl.0000118281.66802.81 · Cited by 120
Self-citation
Calcium signaling in Parkinson’s disease
Calí, T., Ottolini, D., & Brini, M. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1866-0 · Cited by 124
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease
Vitale, C., Santangelo, G., Trojano, L., Verde, F., Rocco, M., Grossi, D., & Barone, P. (2011) · Movement Disorders · doi:10.1002/mds.23567 · Cited by 118
Health-related quality of life in Parkinson’s disease: a cross-sectional study focusing on non-motor symptoms
Kadastik‐Eerme, L., Rosenthal, M., Paju, T., Muldmaa, M., & Taba, P. (2015) · Health and Quality of Life Outcomes · doi:10.1186/s12955-015-0281-x · Cited by 126
Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine
Kimber, J., Watson, L. P. E., & Mathias, C. J. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10168-9 · Cited by 119
The dopamine transporter: Importance in Parkinson's disease
Nutt, J. G., Carter, J. H., & Sexton, G. J. (2004) · Annals of Neurology · doi:10.1002/ana.20089 · Cited by 118
Neuropathogenesis-on-chips for neurodegenerative diseases
Amartumur, S., Nguyen, H. M., Huynh, T., Kim, T. S., Woo, R., Oh, E., Kim, K. K., Lee, L. P., & Heo, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46554-8 · Cited by 131
Overexpression of Neutrophil Neuronal Nitric Oxide Synthase in Parkinson's Disease
Gatto, E. M., Galdo, N. A. R., Carreras, M. C., Cherñavsky, A. C., Rubio, A., Satz, M. L., & Poderoso, J. J. (2000) · Nitric Oxide · doi:10.1006/niox.2000.0288 · Cited by 117
A comprehensive model of health-related quality of life in Parkinson’s disease
Jeukens‐Visser, M., van Rooden, S. M., Verbaan, D., Marinus, J., Stiggelbout, A. M., & van Hilten, J. J. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0994-4 · Cited by 117
Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles
Paulus, W., & Selim, M. (1990) · Acta Neuropathologica · doi:10.1007/bf00662643 · Cited by 117
Dynamic changes in cerebello-thalamo-cortical motor circuitry during progression of Parkinson's disease
Sen, S., Kawaguchi, A., Truong, Y., Lewis, M. M., & Huang, X. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.036 · Cited by 116
Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review
Andersen, A. D., Binzer, M., Stenager, E., & Gramsbergen, J. B. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12590 · Cited by 122
Quantitative Analysis of Bradykinesia and Rigidity in Parkinson’s Disease
di Biase, L., Summa, S., Tosi, J., Taffoni, F., Marano, M., Rizzo, A. C., Vecchio, F., Formica, D., Lazzaro, V. D., Pino, G. D., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00121 · Cited by 116
Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease
Zach, H., Dirkx, M. F., von Roth, D., Pasman, J. W., Bloem, B. R., & Helmich, R. C. G. (2020) · Neurology · doi:10.1212/wnl.0000000000010316 · Cited by 116
The Parkinson disease pain classification system: results from an international mechanism-based classification approach
Mylius, V., Perez‐Lloret, S., Cury, R. G., Teixeira, M. J., Barbosa, V. R., Barbosa, E. R., Moreira, L. I., Listik, C., Fernandes, A. M., Veiga, D. D. L., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000002107 · Cited by 126
Systematic review of paramedical therapies for Parkinson's disease
Deane, K. H., Ellis‐Hill, C., Jones, D. E., Whurr, R., Ben‐Shlomo, Y., Playford, E. D., & Clarke, C. E. (2002) · Movement Disorders · doi:10.1002/mds.10197 · Cited by 112

Authors: Gibb, W. R., & Lees, A. J.
ORCID: Gibb, W R
Lees, A J
Venue: Journal of Neurology, Neurosurgery & Psychiatry
Publisher: BMJ
Published: 1988-06-01
Volume: 51
Issue: 6
Pages: 745-752
ISSN: 0022-3050 (ISSN-L)
DOI: 10.1136/jnnp.51.6.745
PMC: PMC1033142
OpenAlex: W2132881915
Semantic Scholar: 354cd1cf28ad23a8038bb3c576ff7791b3c74543
Cited by: 3,481
References: 39
Citations by year: 2026: 78 · 2025: 130 · 2024: 152 · 2023: 143 · 2022: 131 · 2021: 158 · 2020: 164 · 2019: 152 · 2018: 138 · 2017: 156 · 2016: 163 · 2015: 115 · 2014: 149 · 2013: 123 · 2012: 138
FWCI: 3.24
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
PubMed Central (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: Lewy bodies, Parkinson's disease, pathogenesis, neurofilaments, substantia nigra, incidental Lewy body disease, age-related prevalence, neuronal loss
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Brain, Brain Damage, Chronic, Inclusion Bodies, Child, Humans, Middle Aged, Nerve Degeneration, Parkinson Disease, Substantia Nigra

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks